PALINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
PALISADE BIO, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$1.34−0.07 (-4.96%)
Close on Oct 19, 2026
- Market cap
- $283.25M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| May 13, 2024(first seen in filings) | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |
| Apr 8, 2024 | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |
| Mar 22, 2023(first seen in filings) | 1-for-50 reverse | Earlier per-share figures multiplied by 50 |
| Nov 16, 2022 | 1-for-50 reverse | Earlier per-share figures multiplied by 50 |
| Apr 28, 2021 | 1-for-6 reverse | Earlier per-share figures multiplied by 6 |
| Aug 14, 2019(first seen in filings) | 1-for-20 reverse | Earlier per-share figures multiplied by 20 |
| Jul 18, 2019 | 1-for-20 reverse | Earlier per-share figures multiplied by 20 |
| Mar 23, 2017(first seen in filings) | 1-for-13 reverse | Earlier per-share figures multiplied by 13 |
| Jan 9, 2017 | 1-for-13 reverse | Earlier per-share figures multiplied by 13 |